Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAVVQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,921
Award facts
- Contract value 100% obligated
- $33,921.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, received a $33.9K firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 25, 2025, for DUPIXENT 300 mg/2 ml pen injections. This delivery order, issued without a set-aside designation, is part of DMS Pharmaceutical Group's larger SPE2DB Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026. The pharmaceutical products will be delivered to a location in Conshohocken, Pennsylvania, with a completion date of July 28, 2025, supporting the Defense Department's medical supply needs across military health facilities.
As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the DLA to fulfill critical medication needs for the Department of Defense healthcare system. The company's SPE2DB contract enables the issuance of firm fixed-price delivery orders for an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. This particular delivery order for DUPIXENT, a biologic immunosuppressant medication, reflects the contractor's role in providing specialty pharmaceutical products essential to military medical operations nationwide.
Quick answers
Who was awarded contract SPE2DB25FAVVQ?
SPE2DB25FAVVQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FAVVQ worth?
The government has obligated $33,921 on SPE2DB25FAVVQ.
Is contract SPE2DB25FAVVQ an order under another contract?
Yes. SPE2DB25FAVVQ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVVQ competed?
The extent of competition for SPE2DB25FAVVQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award